Skip to main content
All Posts By

Carevive

Carevive is a health technology company focusing on care management and patient engagement solutions to improve the quality of life and clinical outcomes of cancer patients. Sign up for our newsletter here.

Carevive EOM Open House
Carevive EOM Open House – Webinar Events

Carevive EOM Open House – Webinar

Many of our cancer care partners have experienced financial hardship in recent years. As the shift from volume to value becomes increasingly paramount to profitable operations, administrators are looking for opportunities to boost revenues. Carevive is here to help! Carevive is kicking off our 2023 Revenue Enhancement Opportunity Series, which will include CMS’ Enhancing Oncology Model (EOM), chronic care management,…
Carevive
January 18, 2023
Podcast #19: The New Oncology Model Created to Improve Cancer Care
Podcast #19: The New Oncology Model Created to Improve Cancer Care Podcast

Podcast #19: The New Oncology Model Created to Improve Cancer Care

In the latest episode of “Oncology and Technology,” host Tyler Kern sat down to interview with several members of the Carevive team, John Elliot, VP of Sales; Reesa Sherin, Clinical Strategist; and April Boyd, Clinical Product Manager, mostly about the state of the oncology, and what current trends will remain or seeing advancements next year.
Carevive
January 11, 2023
ISPOR 2022
ISPOR 2022 Podium Presentation Resources

ISPOR 2022 Podium Presentation

Predictors of Symptom Worsening or Improvement using Remote Patient Reported Outcomes (PRO) Technology Carevive is using SMART DATA to identify symptom patterns and predictors leading to an automated alert of severe symptoms and symptom resolution after the alert. Using PROmpt®, a remote symptom reporting platform, patients receiving cancer treatment report symptom presence and severity weekly. Analyses of these data revealed…
Carevive
January 11, 2023
Poster: Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status
Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status PostersResources

Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status

This study demonstrates the feasibility of gathering PROs with real-world data among a cohort of patients with AML using a remote symptom monitoring platform, across baseline prognostic and therapeutic factors.
Carevive
December 12, 2022
Poster: Evaluation Of Treatment Choices At Baseline Among Breast Cancer Patients Based On The Frailty Status Of The Patients
Evaluation Of Treatment Choices At Baseline Among Breast Cancer Patients Based On The Frailty Status Of The Patients PostersResources

Evaluation Of Treatment Choices At Baseline Among Breast Cancer Patients Based On The Frailty Status Of The Patients

Previous studies have shown that frailty scores aid in better patient assessment and in advising treatment strategies for Acute Myeloid Leukemia (AML) (Jamy, et al., 2021), and Multiple Myeloma (Nathwani, et al., 2017, 2019). This study aims to evaluate the impact of frailty status on treatment choices among breast cancer patients.
Carevive
December 9, 2022
Poster: Patient-Reported Symptom Burden in Women Undergoing Treatment for Early-Stage and Metastatic Breast Cancer
Patient-Reported Symptom Burden in Women Undergoing Treatment for Early-Stage and Metastatic Breast Cancer PostersResources

Patient-Reported Symptom Burden in Women Undergoing Treatment for Early-Stage and Metastatic Breast Cancer

Women undergoing treatment for breast cancer experience both disease- and treatment-related symptoms. Remote symptom management (RSM) programs allow real-time symptom documentation, earlier intervention, and opportunities to improve quality of life and decrease symptom burden. Prior studies have focused on the supportive care needs of women with advanced breast cancer.
Carevive
December 9, 2022